NAB-Paclitaxel Examined Against Solvent-Based Paclitaxel in Breast Cancer

Leggi l'articolo originale


Researchers compared invasive disease-free survival rates in patients with breast cancer who took nanoparticle albumin-bound (NAB)-paclitaxel compared with those who took solvent-based (sb)-paclitaxel.

Lascia un commento